Hepatitis a: changes in the epidemiological pattern

Detalhes bibliográficos
Autor(a) principal: Marinho, Rui Tato
Data de Publicação: 2000
Outros Autores: Valente, Ana, Ramalho, Fernando, Moura., M. Carneiro De
Tipo de documento: Artigo
Idioma: por
Título da fonte: Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
Texto Completo: https://doi.org/10.32385/rpmgf.v16i2.9786
Resumo: Introduction: There is evidence, that is corroborated by several other authors, pointing toward a change in the epidemiological patterns of hepatitis A in various European, American, and even Asian countries. Knowing the current prevalence of anti-hepatitis A virus (anti-HAV) antibodies is thus imperative, all the more so that the anti-hepatitis A vaccine has begun to be marketed in Portugal. Objective: To assess the current prevalence of anti-HAV antibodies in an urban population of health professionals and medical students from the Santa Maria Hospital in Lisbon. Population: 526 subjects were studied, of which 325 were health professionals from diverse age and professional groups from the Santa Maria Hospital, and 201 were students from various pre-graduate years of the Medical School. Methods: Total anti-HAV antibodies were determined by an immune-enzymatic assay using a commercial kit. Results: The global prevalence of anti-HAV antibodies was 86.4% in health professionals, and 35.3% in students, this difference being statistically significant (p
id RCAP_8a6010b2c53ae9f6f4a92ac9d6c2f51e
oai_identifier_str oai:ojs.rpmgf.pt:article/9786
network_acronym_str RCAP
network_name_str Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
repository_id_str https://opendoar.ac.uk/repository/7160
spelling Hepatitis a: changes in the epidemiological patternHepatite a: alteração do padrão epidemiológicoHepatite AVacinaEpidemiologiaHepatitis AVaccineEpidemiologyIntroduction: There is evidence, that is corroborated by several other authors, pointing toward a change in the epidemiological patterns of hepatitis A in various European, American, and even Asian countries. Knowing the current prevalence of anti-hepatitis A virus (anti-HAV) antibodies is thus imperative, all the more so that the anti-hepatitis A vaccine has begun to be marketed in Portugal. Objective: To assess the current prevalence of anti-HAV antibodies in an urban population of health professionals and medical students from the Santa Maria Hospital in Lisbon. Population: 526 subjects were studied, of which 325 were health professionals from diverse age and professional groups from the Santa Maria Hospital, and 201 were students from various pre-graduate years of the Medical School. Methods: Total anti-HAV antibodies were determined by an immune-enzymatic assay using a commercial kit. Results: The global prevalence of anti-HAV antibodies was 86.4% in health professionals, and 35.3% in students, this difference being statistically significant (pIntrodução: Existe uma evidência, corroborada por diversos autores, no sentido da alteração dos padrões epidemiológicos da Hepatite A em diversos países não só europeus como também do continente americano e até asiático. O conhecimento da prevalência actual dos anticorpos contra o vírus da hepatite A (anti-VHA), torna-se pois imperativo, reforçado pelo início da comercialização da vacina anti-hepatite A. Objectivo: O objectivo deste estudo consistiu em avaliar a prevalência actual do anticorpo anti-VHA numa população de características urbanas, trabalhadores de saúde e estudantes de Medicina do Hospital Santa Maria em Lisboa. População: Foram estudados 526 indivíduos, 325 profissionais de saúde pertencentes a diversos escalões etários e diferentes grupos profissionais do Hospital e 201 alunos dos diversos anos da Faculdade de Medicina. Métodos: Determinação do anti-VHA total por método imunoenzimático através de Kit comercial. Resultados: A prevalência do anti-VHA global foi de 86,4% nos profissionais de saúde e de 35,3% nos alunos, sendo esta diferença estatísticamente significativa, pAssociação Portuguesa de Medicina Geral e Familiar2000-03-01info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttps://doi.org/10.32385/rpmgf.v16i2.9786https://doi.org/10.32385/rpmgf.v16i2.9786Portuguese Journal of Family Medicine and General Practice; Vol. 16 No. 2 (2000): Revista Portuguesa de Clínica Geral; 103-11Revista Portuguesa de Medicina Geral e Familiar; Vol. 16 Núm. 2 (2000): Revista Portuguesa de Clínica Geral; 103-11Revista Portuguesa de Medicina Geral e Familiar; Vol. 16 N.º 2 (2000): Revista Portuguesa de Clínica Geral; 103-112182-51812182-517310.32385/rpmgf.v16i2reponame:Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)instname:FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologiainstacron:RCAAPporhttps://rpmgf.pt/ojs/index.php/rpmgf/article/view/9786https://rpmgf.pt/ojs/index.php/rpmgf/article/view/9786/9524Marinho, Rui TatoValente, AnaRamalho, FernandoMoura., M. Carneiro Deinfo:eu-repo/semantics/openAccess2024-09-17T11:58:08Zoai:ojs.rpmgf.pt:article/9786Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireinfo@rcaap.ptopendoar:https://opendoar.ac.uk/repository/71602025-05-28T18:50:26.091313Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) - FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologiafalse
dc.title.none.fl_str_mv Hepatitis a: changes in the epidemiological pattern
Hepatite a: alteração do padrão epidemiológico
title Hepatitis a: changes in the epidemiological pattern
spellingShingle Hepatitis a: changes in the epidemiological pattern
Marinho, Rui Tato
Hepatite A
Vacina
Epidemiologia
Hepatitis A
Vaccine
Epidemiology
title_short Hepatitis a: changes in the epidemiological pattern
title_full Hepatitis a: changes in the epidemiological pattern
title_fullStr Hepatitis a: changes in the epidemiological pattern
title_full_unstemmed Hepatitis a: changes in the epidemiological pattern
title_sort Hepatitis a: changes in the epidemiological pattern
author Marinho, Rui Tato
author_facet Marinho, Rui Tato
Valente, Ana
Ramalho, Fernando
Moura., M. Carneiro De
author_role author
author2 Valente, Ana
Ramalho, Fernando
Moura., M. Carneiro De
author2_role author
author
author
dc.contributor.author.fl_str_mv Marinho, Rui Tato
Valente, Ana
Ramalho, Fernando
Moura., M. Carneiro De
dc.subject.por.fl_str_mv Hepatite A
Vacina
Epidemiologia
Hepatitis A
Vaccine
Epidemiology
topic Hepatite A
Vacina
Epidemiologia
Hepatitis A
Vaccine
Epidemiology
description Introduction: There is evidence, that is corroborated by several other authors, pointing toward a change in the epidemiological patterns of hepatitis A in various European, American, and even Asian countries. Knowing the current prevalence of anti-hepatitis A virus (anti-HAV) antibodies is thus imperative, all the more so that the anti-hepatitis A vaccine has begun to be marketed in Portugal. Objective: To assess the current prevalence of anti-HAV antibodies in an urban population of health professionals and medical students from the Santa Maria Hospital in Lisbon. Population: 526 subjects were studied, of which 325 were health professionals from diverse age and professional groups from the Santa Maria Hospital, and 201 were students from various pre-graduate years of the Medical School. Methods: Total anti-HAV antibodies were determined by an immune-enzymatic assay using a commercial kit. Results: The global prevalence of anti-HAV antibodies was 86.4% in health professionals, and 35.3% in students, this difference being statistically significant (p
publishDate 2000
dc.date.none.fl_str_mv 2000-03-01
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://doi.org/10.32385/rpmgf.v16i2.9786
https://doi.org/10.32385/rpmgf.v16i2.9786
url https://doi.org/10.32385/rpmgf.v16i2.9786
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv https://rpmgf.pt/ojs/index.php/rpmgf/article/view/9786
https://rpmgf.pt/ojs/index.php/rpmgf/article/view/9786/9524
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Associação Portuguesa de Medicina Geral e Familiar
publisher.none.fl_str_mv Associação Portuguesa de Medicina Geral e Familiar
dc.source.none.fl_str_mv Portuguese Journal of Family Medicine and General Practice; Vol. 16 No. 2 (2000): Revista Portuguesa de Clínica Geral; 103-11
Revista Portuguesa de Medicina Geral e Familiar; Vol. 16 Núm. 2 (2000): Revista Portuguesa de Clínica Geral; 103-11
Revista Portuguesa de Medicina Geral e Familiar; Vol. 16 N.º 2 (2000): Revista Portuguesa de Clínica Geral; 103-11
2182-5181
2182-5173
10.32385/rpmgf.v16i2
reponame:Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
instname:FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia
instacron:RCAAP
instname_str FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia
instacron_str RCAAP
institution RCAAP
reponame_str Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
collection Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
repository.name.fl_str_mv Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) - FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia
repository.mail.fl_str_mv info@rcaap.pt
_version_ 1833597697716649984

Registros relacionados